Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction

International Journal of Impotence Research

Volumn 19, Issue 4, 2007, Pages 398-406

  King, R ^a   Juenemann, K P ^b   Levinson, I P ^c   Stecher, V J ^c   Creanga, D L ^c  

^a Sydney Centre for Sexual and Relationship Therapy   (Australia)

^b UNIVERSITY OF KIEL   (Germany)

^c PFIZER INC   (United States)

Author keywords

Erectile dysfunction; Satisfaction; Sildenafil citrate

Indexed keywords

PLACEBO; SILDENAFIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EMOTION; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTIMAL DRUG DOSE; PENIS ERECTION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; RATING SCALE; RECOMMENDED DRUG DOSE; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; TREATMENT OUTCOME;

ADULT; AGED; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; EMOTIONS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SULFONES; TREATMENT OUTCOME;

EID: 34347399631     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901549     Document Type: Article

References (40)

1. Data on file. Pfizer Inc., New York, NY, 2005.
2. Gingell C, Sultana S, Hodgson G, Wulff M, Gepi-Attee S. Duration of action of sildenafil citrate in men with erectile dysfunction. J Sex Med 2004; 1: 179-184.
3. Eardley I, Ellis P, Boolell M, Wulff M. Onset and duration of action of sildenafil citrate for the treatment of erectile dysfunction. Br J Clin Pharmacol 2002; 53: 61S-65S.
4. Padma-Nathan H, Stecher VJ, Sweeney M, Orazem J, Tseng LJ, DeRiesthal H. Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial. Urology 2003; 62: 400-403.
5. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78: 257-261.
6. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52.
7. Montorsi F, Padma-Nathan H, Glina S. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra). Urology 2006; 68(Suppl 3A): 26-37.
8. NIH Consensus Development Panel on Impotence. NIH Consensus Conference. Impotence. JAMA 1993; 270: 83-90.
9. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326.
10. Boulton AJ, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia 2001; 44: 1296-1301.
11. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397-1404.
12. Padma-Nathan H. Oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction: assessment of erections hard enough for sexual intercourse. Int J Clin Pract Suppl 1999; 102: 13-15.
13. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
14. Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999; 53: 793-799.
15. Althof SE, Cappelleri JC, Shpilsky A, Stecher V, Diuguid C, Sweeney M et al. Treatment responsiveness of the Self-Esteem And Relationship questionnaire in erectile dysfunction. Urology 2003; 61: 888-892.
16. Dinsmore WW, Hodges M, Hargreaves C, Osterloh IH, Smith MD, Rosen RC. Sildenafil citrate (VIAGRA) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology 1999; 53: 800-805.
17. Cappelleri JC, Althof SE, O'Leary MP, Duttagupta S, Bowler J, Crowley AR et al. Assessing self esteem, confidence, and relationships in men with erectile dysfunction treated with sildenafil citrate: combined analysis of 2 double-blind placebo-controlled trials. Pharmacoepidemiol Drug Saf 2004; 13: S139-S140.
18. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function. Urology 2000; 56: 477-481.
19. DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol 2004; 93: 147-153.
20. Glina S, Bertero E, Claro J, Damiao R, Faria G, Fregonesi A et al. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men. Int J Impot Res 2002; 14(Suppl 2): S27-S32.
21. Glina S, Bertero E, Claro J, Damião R, Faria G, Fregonesi A et al. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in Latin America. Braz J Urol 2001; 27: 148-154.
22. Katz SD, Parker JD, Glasser DB, Bank AJ, Sherman N, Wang H et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure. Am J Cardiol 2005; 95: 36-42.
23. Kongkanand A, Ratana-Olarn K, Ruangdilokrat S, Tantiwong A. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study. J Med Assoc Thai 2003; 86: 195-205.
24. Levinson IP, Khalaf IM, Shaeer KZ, Smart DO. Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa. Int J Impot Res 2003; 15(Suppl 1): S25-S29.
25. Lewis R, Bennett CJ, Borkon WD, Boykin WH, Althof SE, Stecher VJ et al. Patient and partner satisfaction with VIAGRA (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire. Urology 2001; 57: 960-965.
26. Meuleman E, Cuzin B, Opsomer RJ, Hartmann U, Bailey MJ, Maytom MC et al. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction. BJU Int 2001; 87: 75-81.
27. Olsson AM, Persson CA. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in men with cardiovascular disease. Int J Clin Pract 2001; 55: 171-176.
28. Padma-Nathan H, Steers WD, Wicker PA, for the Sildenafil Study Group. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Int J Clin Pract 1998; 52: 375-380.
29. Pickering TG, Shepherd AM, Puddey IB, Glasser DB, Orazem J, Sherman N et al. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens 2004; 17: 1135-1142.
30. Rendell MS, Rajfer J, Wicker PA, Smith MD, for the Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA 1999; 281: 421-426.
31. Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001; 158: 1623-1630.
32. Stuckey BG, Jadzinsky MN, Murphy LJ, Montorsi F, Kadioglu A, Fraige F et al. Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care 2003; 26: 279-284.
33. Tan HM, Moh CL, Mendoza JB, Gana T, Albano GJ, de la Cruz R et al. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. The Assess-1 Study Group. Urology 2000; 56: 635-640.
34. Tignol J, Furlan PM, Gomez-Beneyto M, Opsomer R, Schreiber W, Sweeney M et al. Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression. Int Clin Psychopharmacol 2004; 19: 191-199.
35. Young JM, Bennett C, Gilhooly P, Wessells H, Ramos DE. Efficacy and safety of sildenafil citrate (Viagra®) in black and Hispanic American men. Urology 2002; 60(Suppl 2B): 39-48.
36. Stecher VJ. Near-normalization of erectile function and improvement of psychosocial quality-of-life in men with erectile dysfunction treated with Viagra® (sildenafil citrate). J Sex Med 2005; 83(Suppl 1): P-158.
37. Althof SE, O'Leary MP, Cappelleri JC, Hvidsten K, Stecher VJ, Glina S et al. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: results from an international, multi-center, double-blind, placebo-controlled trial. J Sex Med 2006; 3: 521-529.
38. O'Leary MP, Althof SE, Cappelleri JC, Crowley A, Sherman N, Duttagupta S et al. Self-esteem, confidence, and relationship satisfaction in men with erectile dysfunction treated with sildenafil citrate: a multicenter, randomized, parallel-group, double-blind, placebo-controlled study in the United States. J Urol 2006; 175: 1058-1062.
39. Stecher V, Wang H. Treatment satisfaction with Viagra® (sildenafil citrate) in men with erectile dysfunction: combined analysis of 6 trials. J Sex Med 2005; 4(Suppl 1): 62.
40. Levinson IP, Creanga DL. Appropriate starting dose of VIAGRA® (sildenafil citrate) for the treatment of erectile dysfunction: pooled analysis of flexible-dose, placebo-controlled, double-blind studies and open-label extension. J Sex Med 2005; 2(Suppl 1): 36.